Specialized panels Leverage the proprietary H pylori antibiotic resistance panel as a lead-in for cross-selling infectious disease diagnostics and partner with gastroenterology clinics to expand use cases in antibiotic stewardship programs.

Growth potential With a revenue range of 10–25 million and a lean team, there is room to scale through contract research organization partnerships, performed test migrations, and enterprise lab service agreements with larger healthcare networks.

Digital reach Current tech stack indicates reliance on cloud hosting and web-based marketing; opportunities exist to optimize digital channels, lead generation, and online scheduling with targeted content for hospital systems and private labs.

Healthcare partnerships Position AML as a nimble partner for mid-sized reference laboratories and regional health systems seeking rapid deployment of molecular assays, potentially competing with mid-tier labs to win new accounts.

Competitive positioning Highlight agility and focus on GI and respiratory infectious disease testing to stand out against larger, broader players; offer pilot programs, volume pricing, and data-sharing capabilities to attract customers from peers like Eurofins or NeoGenomics.